When's the Best and Worst Time to Have a Heart Attack?Top of Mind with Julie Rose • Season 1, Episode 767, Segment 2
Mar 13, 2018 • 13m
Guest: Anupam Jena, MD, PhD, Associate Professor of Health Care Policy at Harvard, Physician at Massachusetts General Hospital All around the country, people with common interests or expertise come together for big gatherings. Heart doctors go to cardiology conferences. Gun enthusiasts go to the NRA convention. Runners converge for the Boston Marathon. And when these gatherings happen, there are consequences for public health. Surprising consequences in many cases. For example, what happens to the patients of all those top-flight cardiologists when they’re away at the conference? Do they get worse care from the doctors who fill in? Actually, no. They do better.

23andMe Breast Cancer Genetics TestingMar 13, 201811mGuest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.
Guest: Laura Hercher, MS, Director of Student Research, Joan H. Marks Graduate Program in Human Genetics, Sarah Lawrence College If you send in a sample of your saliva to 23andMe, the genetics-testing company will send you a report about where your ancestors came from, and you can pay extra to find out if you’re at risk for Parkinson’s or Late-Onset Alzheimer’s. Just last week, the Federal Drug Administration also gave 23andMe the green light to screen for three mutations that increase the risk of breast and ovarian cancer. It was screening positive for mutations on these BRCA genes that led Angelina Jolie to have a double mastectomy. This is the first time the FDA has authorized this screening by a company selling directly to consumers.